Oliver Dibben

Oliver Dibben is a Principal Scientist in Virology Research at AstraZeneca, leading a team focused on understanding and enhancing the effectiveness of live attenuated influenza vaccines. With 15 years of postdoctoral academic and industrial experience, Oliver contributed to significant research initiatives at institutions such as the University of Oxford and the Icahn School of Medicine at Mount Sinai, where they explored innate immune responses and developed antiviral drugs. Oliver completed their PhD in Virology at the University of Warwick in 2006 and has held senior scientific roles in virology, emphasizing calm leadership in high-pressure environments.